ZA200506610B - Nutraceuticals for the treatment, protection and restoration of connective tissues - Google Patents

Nutraceuticals for the treatment, protection and restoration of connective tissues Download PDF

Info

Publication number
ZA200506610B
ZA200506610B ZA200506610A ZA200506610A ZA200506610B ZA 200506610 B ZA200506610 B ZA 200506610B ZA 200506610 A ZA200506610 A ZA 200506610A ZA 200506610 A ZA200506610 A ZA 200506610A ZA 200506610 B ZA200506610 B ZA 200506610B
Authority
ZA
South Africa
Prior art keywords
sequence
data
frequency bands
transmission
frequency
Prior art date
Application number
ZA200506610A
Other languages
English (en)
Inventor
Bojang Shen
Peter Ghosh
Original Assignee
Inst Of Nutraceutical Res Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPS0112A external-priority patent/AUPS011202A0/en
Priority claimed from AUPS1054A external-priority patent/AUPS105402A0/en
Application filed by Inst Of Nutraceutical Res Pty filed Critical Inst Of Nutraceutical Res Pty
Publication of ZA200506610B publication Critical patent/ZA200506610B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Mobile Radio Communication Systems (AREA)
ZA200506610A 2002-01-23 2003-01-23 Nutraceuticals for the treatment, protection and restoration of connective tissues ZA200506610B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS0112A AUPS011202A0 (en) 2002-01-23 2002-01-23 Nutraceuticals for the treatment, protection and restoration of connective tissues
AUPS1054A AUPS105402A0 (en) 2002-03-12 2002-03-12 Nutraceuticals for the treatment, protection and restoration of connective tissues

Publications (1)

Publication Number Publication Date
ZA200506610B true ZA200506610B (en) 2006-07-26

Family

ID=27614006

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200506610A ZA200506610B (en) 2002-01-23 2003-01-23 Nutraceuticals for the treatment, protection and restoration of connective tissues
ZA200406621A ZA200406621B (en) 2002-01-23 2004-08-19 Nutraceuticals for the treatment, protection and restoration of connective tissues.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200406621A ZA200406621B (en) 2002-01-23 2004-08-19 Nutraceuticals for the treatment, protection and restoration of connective tissues.

Country Status (8)

Country Link
US (2) US7371820B2 (https=)
EP (1) EP1476471A4 (https=)
JP (1) JP2005519914A (https=)
AU (1) AU2003201402B2 (https=)
CA (1) CA2474269A1 (https=)
NZ (1) NZ534760A (https=)
WO (1) WO2003062279A1 (https=)
ZA (2) ZA200506610B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
AU2003903037A0 (en) * 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
US20080200372A1 (en) * 2004-01-16 2008-08-21 Institute Of Nutraceutical Research Pty Ltd. Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
AU2005202062B2 (en) * 2005-01-14 2012-08-16 Institute Of Nutraceutical Research Pty Ltd Nutraceuticals for the treatment, protection, and restoration of connective tissues
JP4955944B2 (ja) * 2005-06-30 2012-06-20 丸共バイオフーズ株式会社 コンドロイチン硫酸カルシウム及びその製造方法
US7943764B2 (en) * 2005-10-27 2011-05-17 Dimitry Alekseevich Savaschuk Method for producing sulphated glycosaminoglycans from biological tissues
US20080279825A1 (en) * 2007-05-10 2008-11-13 Malinin Theodore I Cartilage material
FR2918376B1 (fr) * 2007-07-04 2011-10-28 Mathieu Borge Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
JP5143621B2 (ja) * 2008-05-08 2013-02-13 電気化学工業株式会社 哺乳動物由来の生体液試料中のヒアルロン酸の分子量分布の測定方法
FR2938762B1 (fr) * 2008-11-21 2011-02-04 Oreal Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee
WO2016111900A1 (en) * 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating arthritis
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
WO2016178945A1 (en) * 2015-05-01 2016-11-10 The Procter & Gamble Company Method of improving the appearance of skin and compositions therefor using nicotinamide riboside
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
KR102114892B1 (ko) 2016-01-11 2020-05-26 더 프록터 앤드 갬블 캄파니 피부 상태의 치료 방법 및 그를 위한 조성물
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
KR20210011964A (ko) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
CN111235202B (zh) * 2018-11-29 2022-03-08 中国中医科学院医学实验中心 一种鹿骨蛋白质提取物及其制备方法与应用
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
CN113603762B (zh) * 2021-08-20 2023-06-27 吉林农业大学 一种花马杂交鹿鹿角盘活性肽及其制备方法和应用
ES2956802B2 (es) * 2022-05-20 2025-10-02 Bioiberica S A U Hidrogeles para su uso en ingenieria de tejidos de la piel

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE857389A (fr) * 1977-08-02 1977-12-01 Marbex Finance Ltd Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000
CA1302880C (en) 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
JP3248170B2 (ja) * 1992-12-11 2002-01-21 マルハ株式会社 コンドロイチン硫酸蛋白複合体含有食品
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6492349B1 (en) * 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
AU7205894A (en) * 1993-06-08 1995-01-03 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
ATE282418T1 (de) * 1996-01-11 2004-12-15 Jagotec Ag Orale verabreichung wirksamer mengen von hyaluronsäure
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
JP4247846B2 (ja) * 1997-07-03 2009-04-02 デュピュイ・スパイン・インコーポレーテッド 架橋ポリサッカリド薬物キャリア
US6025327A (en) 1997-08-08 2000-02-15 Biocell Technology, Llc Hydrolyzed collagen type II and use thereof
US5922692A (en) * 1998-03-11 1999-07-13 Marino; Richard P. Concentration of glycosaminoglycans and precursors thereto in food products
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
JP3271008B2 (ja) * 1999-11-18 2002-04-02 独立行政法人産業技術総合研究所 コンドロイチン硫酸類の製造方法
DE10008896A1 (de) * 2000-02-25 2001-08-30 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolderivaten und Alkylnaphthalaten
NZ522971A (en) * 2000-05-05 2005-02-25 Gtc Biotherapeutics Inc Transgenically produced decorin in the mammary gland of a transgenic animal
US6924273B2 (en) * 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof

Also Published As

Publication number Publication date
CA2474269A1 (en) 2003-07-31
US7371820B2 (en) 2008-05-13
NZ534760A (en) 2006-03-31
AU2003201402B2 (en) 2004-12-09
US20050020500A1 (en) 2005-01-27
JP2005519914A (ja) 2005-07-07
EP1476471A1 (en) 2004-11-17
US20060040851A1 (en) 2006-02-23
ZA200406621B (en) 2005-09-28
EP1476471A4 (en) 2005-03-16
US7211648B2 (en) 2007-05-01
WO2003062279A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2004214058B2 (en) Frequency hop sequences for multi-band communication systems
ZA200506610B (en) Nutraceuticals for the treatment, protection and restoration of connective tissues
US8879378B2 (en) Orthonormal time-frequency shifting and spectral shaping communications method
EP3912340B1 (en) Sub-band and multi-band coded ofdm for high-resolution radar
RU2404529C2 (ru) Способ и устройство для мультиплексирования пилот-сигнала в системе беспроводной связи
EP3934189B1 (en) Random access cyclic prefix dimensioning in wireless networks
EP3211846B1 (en) Multiuser communication methods and devices for code division multiple access
KR102065345B1 (ko) 다중 사용자 코드 분할 다중 접속 통신 방법 및 상응한 송신기, 수신기
US20070177631A1 (en) Multiplexing scheme in a communication system
EP1755299A2 (en) Transmitting/receiving apparatus and method for cell search in a broadband wireless communication system using multiple carriers
CN111684731B (zh) 通信方法、通信设备和网络设备
JP2010516121A (ja) 無線通信システムにおけるパイロット通信
JP2009505503A (ja) シングルキャリアおよびマルチキャリア周波数分割多元接続方式におけるチャネルおよび干渉推定
CN102132519A (zh) 频域pn序列
EP3895498A1 (en) Client device and network access node for transmitting and receiving a random access preamble
EP2624479A1 (en) Preamble sequence detection apparatus
CN112136300A (zh) 通信方法、通信设备和网络设备
HK1087259A (en) Frequency hop sequences for multi-band communication systems